Inovio Pharmaceuticals
INO
$9.90
Share price
-2.94%
Change (1 day)
1,025.00%
Change (1 year)
Categories
Market capitalization of Inovio Pharmaceuticals (INO)
Market cap: $0.23 Billion
As of April 2024 Inovio Pharmaceuticals has a market cap of $0.23 Billion. This makes Inovio Pharmaceuticals the world's 6799th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Inovio Pharmaceuticals from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.23 B | 66.18% |
| 2023 | $0.13 B | -64.23% |
| 2022 | $0.38 B | -62.93% |
| 2021 | $1.04 B | -29.98% |
| 2020 | $1.49 B | 348.22% |
| 2019 | $0.33 B | -13.99% |
| 2018 | $0.38 B | 4.29% |
| 2017 | $0.37 B | -27.44% |
| 2016 | $0.51 B | 5.91% |
| 2015 | $0.48 B | -12.97% |
| 2014 | $0.55 B | -8.57% |
| 2013 | $0.60 B | 746.07% |
| 2012 | $72.08 M | 32.34% |
| 2011 | $54.47 M | -54.91% |
| 2010 | $0.12 B | 3.13% |
| 2009 | $0.11 B | 411.8% |
| 2008 | $22.88 M | -43.22% |
| 2007 | $40.3 M | -65.63% |
| 2006 | $0.11 B | 75.28% |
| 2005 | $66.89 M | -7.83% |
| 2004 | $72.57 M | -8.83% |
| 2003 | $79.6 M | 464.09% |
| 2002 | $14.11 M | -34.69% |
| 2001 | $21.6 M |
End of Day market cap according to different sources
On Apr 18th, 2024 the market cap of Inovio Pharmaceuticals was reported to be:
$0.23 Billion
$0.23 Billion
$0.23 Billion
$0.23 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $352.06 B | 152,069.04% | 🇺🇸 USA |
 Novartis NVS | $191.61 B | 82,720.72% | 🇨🇭 Switzerland |
 Pfizer PFE | $144.13 B | 62,199.28% | 🇺🇸 USA |
 Gilead Sciences GILD | $83.04 B | 35,791.89% | 🇺🇸 USA |
 Merck MRK | $317.51 B | 137,134.51% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $81.33 B | 35,052.39% | 🇬🇧 UK |
 Cleveland BioLabs
CBLI | $49.06 M | -78.79% | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | $2.77 B | 1,098.18% | 🇺🇸 USA |